79339458 - I PEACE

Information

• Trademark
• 79339458

• Source

• Serial Number

  79339458

• Registration Number

  7135012

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 3 - Bleaching preparations and other substances for laundry use
  • 5 - Pharmaceutical and veterinary preparations
  • 39 - Transport
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  September 15, 2021
  2 years ago

• Registration Date

  August 15, 2023
  9 months ago

• Transaction Date

  February 28, 2024
  3 months ago

• Status Date

  August 15, 2023
  9 months ago

• Published for Opposition Date

  May 30, 2023
  a year ago

• Location Date

  August 15, 2023
  9 months ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  CANTONE, KERI H

• Attorney Docket Number

  0162098

  Attorney Name

  M. Scott Alprin

  Law Office Assigned Location Code

  L40

• Owners

  • I Peace, Inc.

Case File Statements

• GS0391: Storage of stem cell and cells; warehousing services for deposited frozen stem cell and cells; consultancy and information relating to warehousing services for deposited frozen stem cell and cells; warehousing services
• GS0051: Stem cells for medical purposes; stem cells for clinical medical purposes; stem cells for veterinary purposes; diagnostic media for bacteriological cultures; cell culture media for microorganism culture for medical use; cell culture for medical use; pharmaceutical preparations for human use derived from iPS cells for treating neural disease, muscular disease, heart disease, skin disease, autoimmune disease, kidney disease, eye disease, diabetes, metabolic liver disease, cancers, blood diseases, reproductive organ diseases, lung disease, ear and throat disease, infectious disease, digestive disease and joint disease; pharmaceutical preparations for human use developed by using iPS cells for treating neural disease, muscular disease, heart disease, skin disease, autoimmune disease, kidney disease, eye disease, diabetes, metabolic liver disease, cancers, blood diseases, reproductive organ diseases, lung disease, ear and throat disease, infectious disease, digestive disease and joint disease; dietary supplements; dietetic preparations adapted for medical purposes
• GS0031: Cosmetics containing culture fluid for human stem cell; cosmetics; bath and cosmetic soaps and laundry and dishwasher detergents; dentifrices; perfumery
• GS0011: Cell culture media for laboratory use, other than for medical or veterinary purposes; microorganism culture media for laboratory use, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; chemicals used as ingredients for manufacture of cosmetics; chemicals for industrial purposes; culture fluid for human stem cell as an ingredient for cosmetics manufacturing; stem cells for research and scientific purposes; cell culture media for scientific or research purposes
• GS0441: Stem cell bank services; medical treatment services by using cultured cells; stem cell therapy services; collection and preservation of stem cells for use in regenerative medicine; collection and preservation of human blood; providing medical information in the field of cells; providing medical information related to regenerative medicine; provision of medical information; medical treatment and diagnosis services by using cultured cells for medical and clinical purposes; medical services; providing information and data for medical diagnosis and treatment; medical treatment and diagnosis by regenerative medicine; medical treatment and diagnosis services by cell therapy; medical treatment and consulting services by cell preparations; medical treatment of speech disorders, breast cancer and infertility, neural disease, muscular disease, heart disease, skin disease, autoimmune disease, kidney disease, eye disease, diabetes, metabolic liver disease, cancers, blood diseases, reproductive organ diseases, lung disease, ear and throat disease, infectious disease, digestive disease and joint disease, not limited to stem cells; preservation of human blood as a supply source of stem cells; clinical medical examination; evaluation of clinical examination for medical purposes; genetic testing for medical purposes; providing medical facilities; Health clinic services; providing health information; dietary and nutritional guidance; rental of medical machines and apparatus
• GS0421: Cell culture services for scientific and research purposes for others; providing scientific information related to cell culture; cytogenetic examination being cytogenic research services for others; testing examination, research and development in the field of regenerative medicine; testing, examination, research and development in the field of cytology; testing, examination, research and development of cosmetics; medical laboratory services; research in the field of pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; conducting clinical trials for pharmaceuticals

Case File Event Statements

• 2/28/2024 - 3 months ago

  34 - LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: LIMN

• 1/1/2024 - 5 months ago

  33 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG

• 12/11/2023 - 6 months ago

  32 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 11/16/2023 - 6 months ago

  31 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 11/15/2023 - 6 months ago

  30 - FINAL DISPOSITION PROCESSED Type: FIMP

• 11/15/2023 - 6 months ago

  29 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 8/15/2023 - 9 months ago

  28 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 8/15/2023 - 9 months ago

  27 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 5/30/2023 - a year ago

  26 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 5/30/2023 - a year ago

  25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 5/30/2023 - a year ago

  24 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/10/2023 - a year ago

  23 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 5/10/2023 - a year ago

  22 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 5/10/2023 - a year ago

  21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 4/25/2023 - a year ago

  20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 4/25/2023 - a year ago

  19 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 4/25/2023 - a year ago

  18 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 4/25/2023 - a year ago

  17 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 4/25/2023 - a year ago

  16 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 1/9/2023 - a year ago

  15 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 1/9/2023 - a year ago

  14 - FINAL REFUSAL E-MAILED Type: GNFR

• 1/9/2023 - a year ago

  13 - FINAL REFUSAL WRITTEN Type: CNFR

• 12/27/2022 - a year ago

  12 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX

• 12/27/2022 - a year ago

  11 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI

• 8/17/2022 - a year ago

  10 - REFUSAL PROCESSED BY IB Type: RFNT

• 7/26/2022 - a year ago

  9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 7/26/2022 - a year ago

  8 - REFUSAL PROCESSED BY MPU Type: RFRR

• 6/28/2022 - a year ago

  7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 6/27/2022 - a year ago

  6 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/19/2022 - a year ago

  5 - ASSIGNED TO EXAMINER Type: DOCK

• 5/17/2022 - 2 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 5/13/2022 - 2 years ago

  3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 5/10/2022 - 2 years ago

  2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI

• 4/28/2022 - 2 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR